Plantar warts are typically resistant to treatment. In recent years, treatments have included administration of intralesional tuberculin; measles, mumps, rubella vaccine; and Candida albicans antigen immunotherapy. To the best of our knowledge, there are no reports of intralesional vitamin D administration for the treatment of warts.
Aim:
To evaluate the efficacy and safety of intralesional vitamin D treatment for plantar warts.
Methods:
Twenty patients with single or multiple plantar warts were included in this study. Vitamin D3 (0.2 mL, 7.5 mg/mL) was injected into the base of the warts after prilocaine (0.1 mL, 20 mg/mL) injection. A maximum of 5 warts were treated in 1 session, with at maximum 2 injections performed at 4-week intervals.
Results:
In total, 16 of 20 patients (80%) showed complete resolution of warts, and 1 patient showed partial resolution. Three patients failed to show any response. No recurrence or serious adverse effects were observed.
Conclusion:
Intralesional vitamin D3 may be an effective treatment option for warts.
GibbsSHarveyISterlingJStarkR. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.
2.
AlghamdiKMKhurramH. Successful treatment of plantar warts with very diluted bleomycin using a translesional multipuncture technique: pilot prospective study. J Cutan Med Surg. 2012;16:250-256.
3.
KimuraUTakeuchiKKinoshitaATakamoriKSugaY. Long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser treatment for refractory warts on hands and feet. J Dermatol. 2014;41:252-257.
4.
El-MohamadyAel-SMearagIEl-KhalawanyMElshahedAShokeirHMahmoudA. Pulsed dye laser versus Nd:YAG laser in the treatment of plantar warts: a comparative study. Lasers Med Sci. 2014;29:1111-1116.
5.
CockayneSCurranMDenbyG. EVerT: cryotherapy versus salicylic acid for the treatment of verrucae—a randomised controlled trial. Health Technol Assess. 2011;15:1-170.
6.
BrugginkSCGusseklooJBergerMY. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ. 2010;182:1624-1630.
7.
ShaheenMASalemSAFouadDAAbd El-FatahAA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2015;28(4):194-200.
8.
LeeJYKimCWKimSS. Preliminary study of intralesional bleomycin injection for the treatment of genital warts. Ann Dermatol. 2015;27:239-241.
9.
GargSBavejaS. Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine. J Cutan Aesthet Surg. 2014;7:203-208.
10.
GundetiMSReddyRGMuralidharJV. Subcutaneous intralesional Ksharodaka injection: a novel treatment for the management of warts: a case series. J Ayurveda Integr Med. 2014;5:236-240.
11.
MajidIImranS. Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study. Indian J Dermatol. 2013;58:360-365.
12.
SinghSChouhanKGuptaS. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts. Indian J Dermatol Venereol Leprol. 2014;80:509-514.
13.
MoscarelliLAnnunziataFMjeshtriA. Successful treatment of refractory wart with a topical activated vitamin D in a renal transplant recipient. Case Rep Transplant. 2011;2011:368623.
14.
RindTOisoNKawadaA. Successful treatment of anogenital wart with a topical vitamin D(3) derivative in an infant. Case Rep Dermatol. 2010;2:46-49.
15.
AlGhamdiKKumarAMoussaN. The role of vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:750-758.
16.
ImagawaISuzukiH. Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients. J Dermatol. 2007;34:264-266.
17.
EgawaKOnoT. Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients. Br J Dermatol. 2004;150:374-376.
18.
BroganelliPChiarettaAFragnelliBBernengoMG. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther. 2012;25:468-471.
19.
KumarPDarLSaldiwalSVarmaSDatt UpadhyayATalwarD. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial. JAMA Dermatol. 2014;150:1072-1078.
20.
NofalANofalEYosefANofalH. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Int J Dermatol. 2015;54:667-671.
21.
ZamanianAMobasherPJaziGA. Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart. Adv Biomed Res. 2014;3:107.
22.
IsçimenAAydemirEHGöksügürNEnginB. Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo-controlled, single-blind randomized study. J Eur Acad Dermatol Venereol. 2004;18:455-458.
23.
ManzLAPelachykJM. Bleomycin-lidocaine mixture reduces pain of intralesional injection in the treatment of recalcitrant verrucae. J Am Acad Dermatol. 1991;25:524-526.
